Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia
Conditions: Indigestion; Diabetes Mellitus Interventions: Drug: Ondansetron 8mg; Drug: Placebo Sponsors: Mayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Mellitus | Dyspepsia | Endocrinology | Gastroenterology | Indigestion | Research | Urology & Nephrology | Zofran